Previous 10 | Next 10 |
Enhanced Leadership – New CEO in Q2 Ample Cash Runway following Financing by Notable Institutional Healthcare Investors SOUTH SAN FRANCISCO, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are ...
Aerpio Pharmaceuticals (NASDAQ: ARPO ) +61% on announcing a second clinical trial with funding from MTEC. More news on: Aerpio Pharmaceuticals, Inc., Whiting Petroleum Corporation, Hepion Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Where can you find the most explosive growth? With small-cap stocks. That's true with nearly any sector. And it's certainly true when it comes to investing in companies focused on fighting COVID-19. There are many small biotechs developing experimental COVID-19 therapies and vaccine candidates....
Some are true believers in the power of sophisticated mRNA vaccines, some go for exotic viral vectors, and some are tied to the time-tested cocktail of attenuated viral particles. Whatever approach you prefer, it's clear there's likely more than one way to make a coronavirus vaccine. At p...
Few stocks have performed better than Vaxart (NASDAQ: VXRT) of late. Year to date, shares of this company are up by more than 3,400%. And despite these massive gains, Vaxart's market cap is still just $1.34 billion, a reasonable level for a clinical-stage biotech. Vaxart's efforts to develo...
Biotech Pulse Biotechs continue to be one of the leading healthcare groups and along with diagnostics represent two of the best segments of healthcare. The first half saw biotechs recover quicker from the March selloff than most of the market, and reach a milestone that took 5 years to achie...
Some of the biggest winners of 2020 so far have been small biotechs that are developing COVID-19 vaccine candidates. Shares of Inovio Pharmaceuticals (NASDAQ: INO) , for example, have soared well over 500% year to date. Vaxart (NASDAQ: VXRT) stock is up more than 3,000%. Some invest...
BERWYN, Pa. , July 27, 2020 /PRNewswire/ -- RM LAW, P.C. announces an investigation on behalf of Vaxart, Inc. ("Vaxart" or the "Company") (NASDAQ: VXRT) investors concerning the Company and its officers' possible violations of federal securities laws. If you purc...
Gainers: Wilhelmina International (NASDAQ: WHLM ) +192% . More news on: Wilhelmina International, Inc., Socket Mobile, Inc., MediciNova, Inc., Stocks on the move, , Read more ...
WISeKey International WKEY -20% . More news on: Vaxart, Inc., PolarityTE, Inc., Sunworks, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
— Cash runway extended into 2026 — — Received one of the largest BARDA-funded Project NextGen Awards to date, up to $453 million — — Company well-capitalized to execute on multiple key clinical and regulatory milestones in COVID-19 and noroviru...
A look at the top 10 most actives in the United States SRIVARU Holding Limited (SVMH) rose 94.8% to $0.2971 on volume of 77,516,058 shares NVIDIA Corporation (NVDA) fell 0.3% to $129.16 on volume of 39,120,242 shares Longeveron Inc. (LGVN) rose 27.0% to $3.415 on volume of 36,214,736 shar...
SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (“Vaxart”) (Nasdaq: VXRT) today announced an underwritten offering of 50,000,000 shares of its common stock at an offering price of $0.80 per share, which is a premium to the last closing price of $0.75 per ...